288 related articles for article (PubMed ID: 23362306)
1. Reduction of indoxyl sulfate by AST-120 attenuates monocyte inflammation related to chronic kidney disease.
Ito S; Higuchi Y; Yagi Y; Nishijima F; Yamato H; Ishii H; Osaka M; Yoshida M
J Leukoc Biol; 2013 Jun; 93(6):837-45. PubMed ID: 23362306
[TBL] [Abstract][Full Text] [Related]
2. Oral adsorbent AST-120 ameliorates endothelial dysfunction independent of renal function in rats with subtotal nephrectomy.
Namikoshi T; Tomita N; Satoh M; Sakuta T; Kuwabara A; Kobayashi S; Higuchi Y; Nishijima F; Kashihara N
Hypertens Res; 2009 Mar; 32(3):194-200. PubMed ID: 19262482
[TBL] [Abstract][Full Text] [Related]
3. Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease.
Fujii H; Nakai K; Fukagawa M
Ther Apher Dial; 2011 Apr; 15(2):125-8. PubMed ID: 21426501
[TBL] [Abstract][Full Text] [Related]
4. Indoxyl Sulfate Contributes to Adipose Tissue Inflammation through the Activation of NADPH Oxidase.
Tanaka S; Watanabe H; Nakano T; Imafuku T; Kato H; Tokumaru K; Arimura N; Enoki Y; Maeda H; Tanaka M; Matsushita K; Fukagawa M; Maruyama T
Toxins (Basel); 2020 Aug; 12(8):. PubMed ID: 32764271
[TBL] [Abstract][Full Text] [Related]
5. Deleterious vascular effects of indoxyl sulfate and reversal by oral adsorbent AST-120.
Six I; Gross P; Rémond MC; Chillon JM; Poirot S; Drueke TB; Massy ZA
Atherosclerosis; 2015 Nov; 243(1):248-56. PubMed ID: 26408929
[TBL] [Abstract][Full Text] [Related]
6. AST-120 ameliorates lowered exercise capacity and mitochondrial biogenesis in the skeletal muscle from mice with chronic kidney disease via reducing oxidative stress.
Nishikawa M; Ishimori N; Takada S; Saito A; Kadoguchi T; Furihata T; Fukushima A; Matsushima S; Yokota T; Kinugawa S; Tsutsui H
Nephrol Dial Transplant; 2015 Jun; 30(6):934-42. PubMed ID: 25878055
[TBL] [Abstract][Full Text] [Related]
7. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.
Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D
BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514
[TBL] [Abstract][Full Text] [Related]
8. Editorial: A missing link? Monocyte activation by uremic toxins in cardiorenal syndrome.
Armstrong EJ; Granick JL; Simon SI
J Leukoc Biol; 2013 Jun; 93(6):821-3. PubMed ID: 23723377
[No Abstract] [Full Text] [Related]
9. Role of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease: experimental and clinical effects of oral sorbent AST-120.
Niwa T
Ther Apher Dial; 2011 Apr; 15(2):120-4. PubMed ID: 21426500
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of uremic toxin indoxyl sulfate-induced endothelial cell dysfunction by Klotho protein.
Yang K; Nie L; Huang Y; Zhang J; Xiao T; Guan X; Zhao J
Toxicol Lett; 2012 Nov; 215(2):77-83. PubMed ID: 23085347
[TBL] [Abstract][Full Text] [Related]
11. Possible involvement of nuclear factor-kappaB inhibition in the renal protective effect of oral adsorbent AST-120 in a rat model of chronic renal failure.
Komiya T; Miura K; Tsukamoto J; Okamura M; Tamada S; Asai T; Tashiro K; Kuwabara N; Iwao H; Yoshikawa J
Int J Mol Med; 2004 Jan; 13(1):133-8. PubMed ID: 14654984
[TBL] [Abstract][Full Text] [Related]
12. Indoxyl sulfate enhances IL-1β-induced E-selectin expression in endothelial cells in acute kidney injury by the ROS/MAPKs/NFκB/AP-1 pathway.
Shen WC; Liang CJ; Huang TM; Liu CW; Wang SH; Young GH; Tsai JS; Tseng YC; Peng YS; Wu VC; Chen YL
Arch Toxicol; 2016 Nov; 90(11):2779-2792. PubMed ID: 26659566
[TBL] [Abstract][Full Text] [Related]
13. Indoxyl sulfate is a nephro-vascular toxin.
Niwa T
J Ren Nutr; 2010 Sep; 20(5 Suppl):S2-6. PubMed ID: 20797565
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein promotes adhesion of monocytes to endothelial cells via NADPH oxidase-mediated oxidative stress.
Huang X; Zhang J; Liu J; Sun L; Zhao H; Lu Y; Wang J; Li J
J Cell Biochem; 2012 Mar; 113(3):857-67. PubMed ID: 22020763
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase.
Sorescu GP; Song H; Tressel SL; Hwang J; Dikalov S; Smith DA; Boyd NL; Platt MO; Lassègue B; Griendling KK; Jo H
Circ Res; 2004 Oct; 95(8):773-9. PubMed ID: 15388638
[TBL] [Abstract][Full Text] [Related]
16. Indoxyl sulfate induces intestinal barrier injury through IRF1-DRP1 axis-mediated mitophagy impairment.
Huang Y; Zhou J; Wang S; Xiong J; Chen Y; Liu Y; Xiao T; Li Y; He T; Li Y; Bi X; Yang K; Han W; Qiao Y; Yu Y; Zhao J
Theranostics; 2020; 10(16):7384-7400. PubMed ID: 32641998
[No Abstract] [Full Text] [Related]
17. Angiotensin-converting enzyme inhibitor attenuates monocyte adhesion to vascular endothelium through modulation of intracellular zinc.
Kojima C; Kawakami A; Takei T; Nitta K; Yoshida M
J Pharmacol Exp Ther; 2007 Dec; 323(3):855-60. PubMed ID: 17878405
[TBL] [Abstract][Full Text] [Related]
18. An oral adsorbent, AST-120, suppresses oxidative stress in uremic rats.
Nakagawa N; Hasebe N; Sumitomo K; Fujino T; Fukuzawa J; Hirayama T; Kikuchi K
Am J Nephrol; 2006; 26(5):455-61. PubMed ID: 17057375
[TBL] [Abstract][Full Text] [Related]
19. Uremic toxicity of indoxyl sulfate.
Niwa T
Nagoya J Med Sci; 2010 Feb; 72(1-2):1-11. PubMed ID: 20229698
[TBL] [Abstract][Full Text] [Related]
20. The role of carbon adsorbent in the conservative management of chronic kidney disease.
Niwa T
Panminerva Med; 2017 Jun; 59(2):139-148. PubMed ID: 27990791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
